Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon C Satchell

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Blood|July 9, 2009
Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndromeLubka T Roumenina, Mathieu Jablonski, Christophe Hue, et al.
Clinical and Translational Medicine|June 1, 2026
Heparanase inhibition prevents glycocalyx damage and albuminuria in experimental minimal change diseaseMichael Crompton, Raina D Ramnath, Kai Betteridge, et al.
Diabetes|November 4, 2018
VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic NephropathyKaren L Onions, Monica Gamez, Nicola R Buckner, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2014
Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell linesLijun Ma, Gregory S Shelness, James A Snipes, et al.
JCI Insight|February 7, 2023
Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyxMichael Crompton, Joanne K Ferguson, Raina D Ramnath, et al.
Cell Metabolism|October 5, 2010
Insulin signaling to the glomerular podocyte is critical for normal kidney functionGavin I Welsh, Lorna J Hale, Vera Eremina, et al.
Cardiovascular Diabetology|February 2, 2024
Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetesMonica Gamez, Hesham E Elhegni, Sarah Fawaz, et al.
Cardiovascular Diabetology|February 20, 2024
Correction: Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetesMonica Gamez, Hesham E Elhegni, Sarah Fawaz, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2020
A role for NPY-NPY2R signaling in albuminuric kidney diseaseAbigail C Lay, A Fern Barrington, Jenny A Hurcombe, et al.
EMBO Molecular Medicine|May 27, 2026
Mitochondrial activity promotes neutrophil degranulation and endothelial dysfunction in systemic infectionsPrzemysław Zakrzewski, Christopher M Rice, Claire Naveh, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Blood|July 9, 2009
Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndromeLubka T Roumenina, Mathieu Jablonski, Christophe Hue, et al.
Clinical and Translational Medicine|June 1, 2026
Heparanase inhibition prevents glycocalyx damage and albuminuria in experimental minimal change diseaseMichael Crompton, Raina D Ramnath, Kai Betteridge, et al.
Diabetes|November 4, 2018
VEGFC Reduces Glomerular Albumin Permeability and Protects Against Alterations in VEGF Receptor Expression in Diabetic NephropathyKaren L Onions, Monica Gamez, Nicola R Buckner, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2014
Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell linesLijun Ma, Gregory S Shelness, James A Snipes, et al.
JCI Insight|February 7, 2023
Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyxMichael Crompton, Joanne K Ferguson, Raina D Ramnath, et al.
Cell Metabolism|October 5, 2010
Insulin signaling to the glomerular podocyte is critical for normal kidney functionGavin I Welsh, Lorna J Hale, Vera Eremina, et al.
Cardiovascular Diabetology|February 2, 2024
Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetesMonica Gamez, Hesham E Elhegni, Sarah Fawaz, et al.
Cardiovascular Diabetology|February 20, 2024
Correction: Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetesMonica Gamez, Hesham E Elhegni, Sarah Fawaz, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2020
A role for NPY-NPY2R signaling in albuminuric kidney diseaseAbigail C Lay, A Fern Barrington, Jenny A Hurcombe, et al.
EMBO Molecular Medicine|May 27, 2026
Mitochondrial activity promotes neutrophil degranulation and endothelial dysfunction in systemic infectionsPrzemysław Zakrzewski, Christopher M Rice, Claire Naveh, et al.
Pageof 10